Riskpilot← Back to searchSign inGet full accessBIOBAXQUALITY ApS
APSActiveCVR 26349230Smedievej 17Business and other management consultancy activities · NACE 7020Est. 20011 employees
Revenue 2025
DKK 192K
-56% vs 2024
EBITDA margin
-0.6%
-107% vs 2024
Equity ratio
83.7%
Financial strength
Net profit 2025
DKK -2K
-119% vs 2024
| Revenue | DKK 192K | -56% |
| EBITDA | DKK -1K | -107% |
| Net profit | DKK -2K | -119% |
| Total assets | DKK 340K | -46% |
| Equity | DKK 285K | -1% |
| Employees | 1 | — |
Legal name
BIOBAXQUALITY ApS
CVR number
26349230
Legal form
Anpartsselskab
NACE code
7020 · Business and other management consultancy activities
Founded
1. oktober 2001
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af een direktør.
Company purpose
Selskabets formål er handel, service og konsulentvirksomhed, herunder rådgivning indenfor ledelse og kvalitet.
Address
Smedievej 17
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | — | 0 | 9 | 42 | 52 | 50 | 42 | 106 | 67 | 446 | 640 | 433 | 192 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -13 | -45 | -62 | -307 | -641 | -417 | -193 |
| EBITDA | -5 | -5 | -5 | 1 | 24 | 23 | 32 | 29 | 61 | 5 | 139 | -1 | 16 | -1 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -5 | -5 | -5 | 1 | 24 | 23 | 32 | 29 | 61 | 5 | 139 | -1 | 16 | -1 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 | -0 | -3 | -3 | -1 | -1 | -0 |
| Profit before tax | -5 | -5 | -5 | 1 | 24 | 23 | 32 | 26 | 61 | 2 | 137 | -3 | 15 | -1 |
| Tax | -1 | -1 | -1 | 2 | 6 | 8 | 8 | 8 | 14 | 1 | 31 | 1 | 4 | 1 |
| Net profit | -4 | -4 | -5 | -1 | 18 | 14 | 24 | 18 | 47 | 1 | 106 | -3 | 11 | -2 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 87 | 83 | 78 | 81 | 98 | 112 | 159 | 176 | 270 | 287 | 545 | 509 | 628 | 340 |
| Equity | 61 | 58 | 53 | 52 | 69 | 83 | 108 | 125 | 172 | 173 | 279 | 276 | 287 | 285 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 25 | 25 | 26 | 29 | 29 | 29 | 52 | 50 | 98 | 114 | 266 | 233 | 341 | 56 |
| Total debt | 25 | 25 | 26 | 29 | 29 | 29 | 52 | 50 | 98 | 114 | 266 | 233 | 341 | 56 |
EBITDA margin
-0.6%
This company
15.8%
Market median
-104% vs market
20122025
Equity ratio
83.7%
This company
38.2%
Market median
+119% vs market
20122025
Return on equity
-0.7%
This company
18.4%
Market median
-104% vs market
20122025
Net profit margin
-1.1%
This company
8.1%
Market median
-114% vs market
20122025
Asset turnover
0.56×
This company
1.12×
Market median
-50% vs market
20122025
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KB Audit | Audit | 2001 | — | — |
EL Audit | Audit | 2006 | — | — |
VC Management | Management | 2001 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50.0% | 50.0% | 2015 | |
| Individual | 20.0% | 20.0% | 2015 | |
| Individual | 20.0% | 20.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOBAXQUALITY ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl-Alfred Brylle | Audit | 0 companies |
| Erik Lund-Larsen | Audit | 0 companies |
| Victor Christoffersen | Management | 0 companies |